Phytochemical-mediated green synthesis, mechanistic insights integrated with biological evaluation, density functional theory calculations and molecular docking studies of copper oxide nanoparticles Authors: Annu Devi, Madhu, Ashu Chaudhary Published: 2026 ABSTRACT AbstractCopper oxide nanoparticles have attracted considerable attention due to their notable roles in catalysis, sensing technologies, and biomedical research. In the present work, copper oxide nanoparticles (CuONPs) were prepared through a green synthetic strategy employing aqueous extracts of Azadirachta indica and Aloe vera as natural reducing and capping agents. This plant-assisted approach offers an eco-friendly, economical, and sustainable substitute for traditional chemical synthesis routes that often involve hazardous reagents. Comprehensive characterization techniques were used to confirm nanoparticle formation and evaluate their properties. FTIR analysis showed a distinct Cu–O stretching band near 542 cm− 1, verifying the formation of copper oxide. XRD patterns confirmed the crystalline nature of the particles, with an average crystallite size of about 26.3 nm. Microscopic studies (SEM and TEM) revealed nanoscale particles mainly distributed between 20 and 50 nm with an average particle size of approximately 34 nm. Elemental analysis by EDX verified copper and oxygen as the dominant elements, with weight percentages of 77.51% and 22.49%, respectively, confirming the successful formation of CuONPs, while Zeta potential measurements revealed a zeta potential value of 4.93 mV with a polydispersity index (PDI) of 0.454, indicating moderate colloidal stability and a relatively broad particle size distribution of the synthesized CuONPs. Biological investigations demonstrated strong activity, with over 70% inhibition observed in antioxidant and anti-inflammatory assays at higher concentrations. Additionally, CuONPs exhibited highest antimicrobial activity against B. subtilis with zone of inhibition 23 ± 0.6 mm. Theoretical studies using density functional theory and molecular docking supported the experimental findings. Collectively, the study highlights the promising biomedical potential of green-synthesized CuONPs.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-58053-5.Keywords: Green synthesis, CuONPs, Antioxidant, DFT, Molecular dockingSubject terms: Biochemistry, Biotechnology, Chemistry, Materials science, Nanoscience and technology Introduction Nanotechnology plays a crucial role in driving the development of sustainable technologies for future1. Nanoparticles are regarded as fundamental components for advancing next-generation technologies, with applications spanning numerous industrial fields2. Among them, metal and metal oxide nanoparticles have gained significant attention due to their versatile uses. Transition metal oxides, in particular, represent a vital category of semiconducting materials, widely utilized in magnetic storage devices, solar energy conversion, electronics, gas sensing, and catalytic processes3. A wide range of methodologies exists for nanoparticle synthesis, including chemical, physical, biological, and hybrid techniques. Various methods for fabricating nanocomposites have been extensively reported in the literature, such as the sol–gel process, chemical solution deposition, chemical vapor deposition, hydrolysis co-precipitation, wet chemical synthesis, electro-deposition, the Langmuir–Blodgett technique, and catalytic pathways4–6. Metallic nanoparticles have gained significant attention in the biomedical and pharmaceutical sectors as an alternative strategy to combat the increasing prevalence of various diseases and the emergence of drug-resistant strains7. Conventional chemical synthesis methods often pose biological hazards and adverse effects; therefore, the use of plant extracts particularly in aqueous media for nanoparticle synthesis is becoming a promising green alternative8. These plant-mediated nanoparticles are ecofriendly, non-toxic, safe, and cost-effective. The biomolecules present in plant extracts serve as both reducing and capping agents, enhancing the stability and functionality of the synthesized nanoparticles9. The involvement of hazardous chemical reagents in conventional nanoparticle fabrication restricts their suitability for biomedical and clinical applications10. Accordingly, the advancement of sustainable, biocompatible, and low-toxicity strategies for nanoparticle fabrication has become a significant research priority. In this context, increasing emphasis is being placed on green chemistry principles and biologically mediated synthetic approaches as viable alternatives to conventional methods. These strategies emphasize the use of environmentally benign, economically feasible, and biologically compatible reducing agents for the preparation of copper nanoparticles. Gold nanoparticles have found extensive applications in tumor detection, angiogenesis studies, diagnosis of genetic diseases and disorders, photoimaging, and photothermal therapy. Iron oxide nanoparticles are widely employed in cancer treatment, hyperthermia, targeted drug delivery, and magnetically controlled therapeutic systems11–13. Silver nanoparticles exhibit remarkable antimicrobial, anticancer, and anti-inflammatory properties and are also used for treating skin infections14. Zinc and titanium nanoparticles are commonly utilized as ultraviolet (UV) blocking agents in cosmetic formulations15, while copper nanoparticles have shown promising potential in anticancer therapy16. These nanoparticles have attracted increasing attention due to the escalating challenge of antibiotic resistance. They have been incorporated as antibacterial agents in a range of products, including burn and wound healing creams as well as skincare formulations17,18. Importantly, two COVID-19 vaccines incorporating lipid-based nanoparticle systems received authorization from the U.S. Food and Drug Administration and the European Medicines Agency. In these formulations, lipid nanoparticles encapsulate messenger RNA encoding the SARS-CoV-2 spike glycoprotein, thereby safeguarding the nucleic acid cargo and facilitating its efficient intracellular delivery19. In diagnostics, numerous nanoparticle-based techniques have also been developed. These techniques are designed to detect specific biological agents or diagnose diseases through surface functionalization20. Similarly, metal nanoparticles have been applied in bone-related therapies, where they aid in promoting osteoblast formation and contribute to reducing bone inflammation and enhancing bone regeneration21. Commonly used metals in nanoparticle synthesis include silver (Ag), gold (Au), palladium (Pd), iron (Fe), platinum (Pt), nickel (Ni), cobalt (Co), and copper (Cu), along with their oxide forms such as iron oxide (Fe3O4), zinc oxide (ZnO), and copper oxide (CuO), among others22,23. Copper oxide nanoparticles (CuONPs) synthesized via green methodologies are generally considered to exhibit reduced toxicity and improved biocompatibility, characteristics that are particularly advantageous for biomedical applications24, including drug delivery systems, cosmetic formulations, and incorporation into medical implant materials. Among these, copper has attracted significant attention due to its biological relevance, strong antimicrobial activity, relatively low toxicity, and cost-effectiveness compared to gold and silver25. Azadirachta indica A. Juss. (A. indica), a member of the Meliaceae family, possesses significant therapeutic potential in the treatment of various diseases. The plant contains a diverse range of bioactive compounds such as nimbin, nimbidin, nimbolide, and limonoids, which contribute to disease management by influencing multiple genetic and biochemical pathways. In addition, its polyphenolic flavonoids exhibit strong antifungal and antibacterial properties. Several studies have documented the wide spectrum of biological and pharmacological effects of neem, including antibacterial, antifungal, anti-inflammatory, antiarthritic, antipyretic, hypoglycemic, anti-ulcer, and antitumor activities26–29. A comprehensive review has also outlined the diverse therapeutic applications of A. indica30. Aloe vera (L.) Burm.f (A. vera) is ideal for synthesizing zinc and copper nanoparticles because its bioactive compounds—such as polysaccharides, proteins, and polyphenols—act as natural reducing agents. These molecules also stabilize the nanoparticles, preventing aggregation and controlling their size and shape. Additionally, this green approach is eco-friendly, non-toxic, and can enhance the nanoparticles’ biological activities. Despite extensive reports on chemically synthesized copper oxide nanoparticles, limited studies have systematically explored plant-mediated synthesis routes that integrate eco-friendly fabrication with comprehensive physicochemical and biological evaluation. Therefore, the main objective of this study was to synthesize CuONPs through an eco-friendly green synthesis approach using A. indica and A. vera extracts and to characterize the synthesized nanoparticles using various analytical techniques. Another objective was to evaluate their antibacterial, antifungal, antioxidant, and anti-inflammatory activities for potential biomedical applications. The novelty of the present work lies in the simultaneous utilization of A. indica and A. vera extracts for the green synthesis of CuONPs. Although several studies have reported the green synthesis of CuONPs using either A. indica or A. vera extracts individually, limited studies have explored the synergistic effect of combining both extracts to achieve enhanced reduction efficiency, stabilization, and multifunctional bioactivity. The dual-extract approach provides synergistic phytochemical interactions, where A. indica derived polyphenols and flavonoids promote efficient reduction of copper ions, while A. vera polysaccharides and biomolecules enhance nanoparticle stabilization and growth control. This combined biogenic system may improve particle uniformity, surface functionalization, stability, and biological activity while maintaining an environmentally benign synthesis route. Furthermore, long-term stability studies and comparative evaluation with standard commercial antimicrobial agents were not explored in the present work, which could be considered as limitations of the study. Materials and methods The laboratory-grade cupric sulphate (98%) and other reagents were acquired from Sigma Aldrich. Whatman filter paper no.1 and deionized water were utilized to prepare the compounds as starting materials. To prevent possible contamination, every glassware was carefully cleaned, rinsed with distilled water, and dried in an oven before being used. A. indica and A. vera were obtained from the Kurukshetra University site with permission from the concerned authorities. The plant material was authenticated by Prof. B.D. Vashistha, Botany Department, Kurukshetra University and a voucher specimen (Herbarium/AD/2/2023) was deposited for future reference. All experimental procedures involving plant materials were conducted in accordance with relevant institutional, national, and international guidelines and regulations. The pH of the prepared solutions was measured using a pH testing kit (INSIF, India). CuONPs were synthesized through extract method31 as described below. Preparation of A. indica extract The A. indica leaves were washed, allowed to dry for a week in the shade, and then ground into a fine powder. Ten grams of this powder were mixed with 100 mL of deionized water (1:10) in a 250 mL Erlenmeyer flask, and the mixture was digested for an hour at 80 °C in a hot water bath. The resulting aqueous extract filtrate was then allowed to cool to room temperature before being filtered using a muslin cloth and Whatmann No. 1 filter paper, which is stored at 4 °C for use in the biosynthesis of CuONPs. The obtained extract was labelled as A. Preparation of A. vera extract A. vera leaves were cleaned with distilled water, dried, and the gel was extracted. In a 250 mL Erlenmeyer flask, 10 g of fresh A. vera pulp and 100 mL of deionized water were mixed, and the mixture was gently heated for fifteen minutes. The solution was allowed to cool to room temperature before being filtered through Whatmann No. 1 filter paper and a muslin towel to get the aqueous extract filtrate. The filtrate is stored at 4 °C for eventual use in the production of CuONPs. The obtained extract was labelled as B. Phytochemical screening-qualitative analysis For phytochemical screening and qualitative analysis, fresh extracts of A. indica and A. vera were utilized. Standard phytochemical techniques were used for preliminary phytochemical screening32. Test for carbohydrates One milliliter of Molish’s reagent and a few drops of strong sulfuric acid were added to two milliliters of extract. Carbohydrates are indicated by the presence of purple or reddish hues. Test for tannis Two milliliters of 5% ferric chloride were added to one milliliter of extract. Tannis is present when a dark blue or greenish black color forms. Test for flavonoids One milliliter of 2 N sodium hydroxide was added to two milliliters of extract. Flavonoids are indicated by the presence of a yellow hue that fades with acidity. Test for alkaloids Two milliliters of strong hydrochloric acid were added to two milliliters of extract. Mayer’s reagent was then added in a few drops. Alkaloids are indicated by the presence of green or white precipitate. Test for anthraquinone A precise few drops of a 10% ammonia solution were added to one milliliter. Anthraquinone is present when a pink precipitate appears. Test for anthocyanosides When 1 milliliter of the filtrate and 5 milliliters of diluted HCl are combined, a faint pink hue signifies a positive test. Test for saponins After adding 2 milliliters of distilled water to 2 milliliters of extract, the graduated cylinder was shaken lengthwise for 15 min. The presence of saponins is indicated by the formation of a 1 cm layer of foam. Test for phytosterols Add a few drops of concentrated H2SO4 to two milliliters of extract, shake, and let stand. Phytosterols are indicated by the appearance of red. Preparation of copper oxide nanoparticles (CuONPs) Make a 1:1 (v/v) mixture of extracts A and B. CuSO4 aqueous solutions were used for the biosynthesis of CuONPs. A 90 mL aqueous solution of 1.0 mM cupric sulphate was added to a round-bottom flask and heated to 80 °C while being constantly stirred after the conditions necessary for the synthesis of CuONPs were optimized. At first, the solution’s blue color was noted. A magnetic stirrer set to 700 rpm was then used to vigorously stir the copper solution after 10 mL of mixed plant extract was added dropwise. The solution’s color shifted from light blue to light green, and a brown precipitate started to form after a short while. After maintaining the reaction conditions for an hour, the temperature was lowered to room temperature. The brown precipitate solution was then centrifuged for 10 min at 8000 rpm. To get rid of any unreacted reagent, the precipitate was rinsed twice with distilled water (5 mL) and once with anhydrous ethanol (5 mL). In order to obtain the CuONPs, the dark powder was finally dried using a hot air oven. The obtained yield (~ 72.8%) indicates efficient phytochemical-mediated conversion of Cu2+ ions into CuONPs. Furthermore, the synthesis was repeated under identical conditions and showed consistent nanoparticle formation and comparable characterization results, confirming the reproducibility of the method. The green synthesis of CuONPs is shown in Fig. 1. Synthetic procedure for green synthesis of CuONPs. Synthetic mechanism for synthesis of CuONPs The green synthesis of CuONPs using mixed plant extracts of A. indica and A. vera is primarily mediated by the diverse phytochemicals naturally present in these extracts. The synthesis of CuONPs using a combined A. indica and A. vera extract involves initial reduction of Cu2+ ions (metal precursor Cu2+ salt i.e. CuSO4) by phenolic, carbonyl, and amine functional groups present in the phytochemicals, followed by controlled hydrolysis and nucleation of Cu(OH)2 clusters. In plant-mediated synthesis, the phytochemicals include polyphenols and flavonoids, which are mainly used as complexing and stabilizing agents to facilitate the nucleation and growth of CuONPs rather than reducing Cu2+ to metallic copper. These phytochemicals further regulate local supersaturation and particle growth through their mild reducing and metal-complexing abilities. In addition, the biomolecules adsorb onto the nanoparticle surface and act as capping/stabilizing agents, minimizing uncontrolled aggregation and influencing morphology. During calcination, organic residues are removed and [Cu(OH)2] is transformed into crystalline CuONPs. Thus, the plant phytochemicals are responsible for reduction/complexation, nucleation control, surface stabilization, and morphology regulation during nanoparticle synthesis. Instrumental methods Fourier transform infrared (FTIR) Spectroscopy The Perkin Elmer 1600 FT-IR spectrophotometer was used to evaluate the biosynthesized CuONPs in the 400–4000 cm− 1 range utilizing KBr pellet methods, which involved mixing solid samples with powdered KBr. To determine the biomolecules in the reduction of Cu2+ ions and capping of the reduced copper oxide nanoparticles produced using plant extract, FTIR spectroscopy analysis was performed. X-Ray diffraction In order to measure the X-ray diffraction (XRD) of bio-reduced copper oxide nanoparticles, the dried CuONPs were uniformly coated on an XRD grid, and the spectrum was recorded using a Bruker AXS D8 Advance diffractometer over the 2θ range of 10–900, employing monochromated Cu-K α-radiation (40 kV, 30 mA) at 25 °C to assess phase purity and crystallinity. UV-Visible The electronic spectrum of the complexes was captured using a Perkin Elmer-25 spectrophotometer in dimethyl sulfoxide (DMSO) at room temperature. SEM and EDX Scanning electron microscopy (SEM) provided further insight into the surface morphology of the CuONPs. SEM studies were performed on a JEOL JSM-6390LV SEM microscope operating at an accelerating voltage of 3 kV. Since CuONPs are non-conductive, the samples were uniformly coated with a thin layer of gold to minimize surface charging effects during electron beam irradiation. Gold coating was performed under vacuum conditions to enhance electrical conductivity and improve image resolution. Energy Dispersive X-Ray (EDX) analysis was supported by a Bruker energy-dispersive X-ray spectrometer (EDX). TEM and SAED Transmission Electron Microscopy (TEM) analysis was carried out to examine the morphology, particle size, and structural characteristics of the synthesized nanoparticles. For sample preparation, the synthesized CuONPs were dispersed in ethanol and ultrasonicated for 15 min to obtain a uniform suspension. A drop of the well-dispersed solution was placed onto a carbon-coated copper grid and allowed to dry at room temperature prior to imaging. TEM analysis was performed using an FEI Tecnai G2 20 S-TWIN Transmission Electron Microscope operated at an accelerating voltage of 200 kV by preparing thin films of the sample and mounting them on carbon-coated copper grids to study the morphology and microstructure of the samples. Selected Area Electron Diffraction (SAED) analysis was carried out using a Transmission Electron Microscope to determine the crystalline nature and phase structure of the synthesized nanoparticles. DLS and particle size Dynamic Light Scattering (DLS) analysis was performed to determine the hydrodynamic particle size and size distribution of the synthesized nanoparticles. The measurements were carried out using a Dynamic Light Scattering instrument (Malvern zeta sizer nano ZS, U.K) at 25 °C temperature. For analysis, CuONPs were dispersed in distilled water and ultrasonicated for 15 min to obtain a homogeneous suspension. The sample was filtered to remove large aggregates before measurement. Biocidal evaluation Antioxidant activity The capacity of CuONPs to quench DPPH (2,2-diphenyl-1-picrylhydrazyl), a persistent free radical, was implemented to assess their radical quenching33. The capability of the synthesized nanoparticless to quench DPPH radicals was determined by observing absorbance changes at 517 nm at various concentrations in the range 20–200 µg/mL in dimethyl sulfoxide (DMSO), with ascorbic acid employed as the standard. 0.1mM DPPH solution was prepared in methanol and the prepared solutions (2 mL) were blended with 1 mL of 0.1 mM DPPH solution was incubated at 35 °C in dark for 30 min. Sample absorbance was monitored at 517 nm using DPPH, with methanol employed as a blank reference. The drop in DPPH absorbance at 517 nm, along with the color change, reflects the free radical scavenging activity of an antioxidant, which stabilizes radicals by electron or hydrogen donation. The corresponding percentage inhibition was calculated by Eq. 1: In this equation, Abscontrol indicates the absorbance of the blank (DPPH + DMSO), whereas Abssample indicates the sample’s absorbance. In-vitro anti-inflammatory evaluation The anti-inflammatory property of the freshly formulated CuONPs were assessed via the egg albumin method34. The compounds were solubilized in DMSO to create stock solutions at concentrations of 10, 20, 30, 40, 50, 60 and 70 µg/mL. To prepare the reactive mixture, 2 mL of stock solution was coupled with 2.8 mL of phosphate-buffered saline and 0.2 mL of egg albumin. The system was first kept at 37 °C for 15 min and then exposed to 70 °C for 5 min. After cooling, the absorbance was measured at 660 nm. Double-distilled water was used to prepare the control sample. Sodium diclofenac, served as a control drug, was managed similarly at concentrations of 10, 20, 30, 40, 50, 60 and 70 µg/mL, and the absorbance was recorded. The inhibition rate of protein denaturation was computed by Eq. 2: Here, As indicates the sample absorbance, and Ac corresponds to the control absorbance. The IC50 value was determined and compared against the reference drug. Antibacterial activity The antibacterial activity of CuONPs was evaluated using bacterial strains obtained from the microbiology laboratory. The tested microorganisms included Gram-positive Staphylococcus aureus (S. aureus) and Bacillus subtilis (B.subtilis), as well as Gram-negative Escherichia coli (E. coli) and Klebsiella pneumonia (K. pneumonia)35,36. These strains were selected because they are well-established model microorganisms frequently used in antimicrobial studies to evaluate the broad-spectrum antibacterial efficacy of newly synthesized nanoparticles. S. aureus was selected as a representative due to its clinical importance in skin infections, wound infections, and multidrug-resistant diseases. B. subtilis was chosen because of its well characterized cell wall structure and widespread use in evaluating antibacterial mechanisms. Among Gram-negative bacteria, E. coli was selected because it is one of the most common human pathogens associated with gastrointestinal and urinary tract infections and is widely used as a standard indicator organism in antibacterial assays. K. pneumonia was taken due to its clinical relevance as an opportunistic pathogen known for causing respiratory infections, as well as its increasing multidrug resistance. The inclusion of both Gram-positive and Gram-negative bacteria enabled assessment of the antibacterial activity of CuONPs against microorganisms possessing different cell wall architectures. Gram-positive bacteria possess a thick peptidoglycan layer, whereas Gram-negative bacteria contain an additional outer lipopolysaccharide membrane, which can influence nanoparticle interaction and antibacterial susceptibility. Therefore, selecting these strains allowed comprehensive evaluation of the broad-spectrum antimicrobial potential of the synthesized CuONPs. Antibacterial efficacy was assessed using the disk diffusion method33. Initially, bacterial cultures were grown in nutrient broth under sterile conditions to ensure optimal growth. Each bacterial strain was subsequently inoculated into 15 mL of fresh sterile nutrient broth and incubated at 37 °C for 24 h. Muller–Hinton agar medium was prepared, sterilized by autoclaving, and poured into Petri dishes for antibacterial assessment. The synthesized nanoparticles were dispersed in DMSO and applied onto sterile disks placed on agar plates previously swabbed with bacterial suspensions. DMSO served as the negative control, as it exhibited no inhibitory activity against the tested bacterial strains. Levofloxacin was used as the standard positive control for comparison under identical experimental conditions. The antibacterial activity of the nanoparticles was evaluated at concentrations of 500, 700, and 900 µg/mL. After incubation at 37 °C for 24 h, the diameters of the inhibition zones formed around the disks were measured in millimeters. The antibacterial potential of the nanoparticles was quantified based on the size of the inhibition zones, providing a reliable assessment of their effectiveness against both Gram-positive and Gram-negative bacteria. The %Antimicrobial activity index was calculated by Eq. 3. Antifungal evaluation The antifungal potential of the synthesized nanoparticles was investigated via disc diffusion assay against two pathogenic fungi, Candida albicans (C. albicans) and Aspergillus niger (A. niger)37–40. These fungal strains were chosen because they are commonly found fungal pathogens that can affect human health and the environment. C. albicans is known to cause infections in humans, while (A) niger is associated with respiratory infections and food contamination. Studying both fungi helped evaluate the antifungal potential of CuONPs against different types of fungal organisms. All experiments were carried out on PDA medium, and control plates containing DMSO alone were used for comparison. The synthesized samples were dissolved in DMSO at varying concentrations and applied onto PDA medium. The test fungi were cultivated on nutrient agar by evenly distributing them over the associative Petri dishes. After adding minimal amount of ethanol, the plates were sealed in polybags and cultured at 25 ± 2 °C for 96 h. After incubation, the diameter of the inhibition zone was measured in millimeters. The antifungal activity of individual synthesized compound was measured relative to the standard reference drug, fluconazole (20 µg per disc). Fluconazole was selected as the reference due to its distinct mechanism of action. Unlike amphotericin B, which exerts its antifungal effect by binding directly to ergosterol in the fungal cell membrane, fluconazole inhibits ergosterol biosynthesis. This difference in mode of action is significant, as the concurrent use of both drugs could potentially lead to antagonistic interactions. Theoretically, fluconazole-induced depletion of ergosterol in fungal cell membranes may antagonize the binding and antifungal action of amphotericin (B) Fluconazole is preferred due to its consistent efficacy against a wide range of fungal strains. Following the observation of fungal propagation, the percentage of suppression was noted by employing the formula given in Eq. 4: In the above formula, C and T indicate the diameters of fungal colonies on the control and test plates, respectively. Statistical analysis All experimental data were statistically analyzed and graphically represented using OriginPro software. The results were expressed as mean ± standard deviation (SD) from triplicate experiments. One-way analysis of variance (ANOVA) was employed to evaluate the statistical significance of differences among the experimental groups in antioxidant, anti-inflammatory, antibacterial, and antifungal assays of the synthesized CuONPs. Statistical analysis confirmed significant variations in the biological activities of CuONPs at different concentrations, with p < 0.05, p < 0.01 considered statistically significant. Computational studies Density functional theory calculations The experimental study was complemented by (density functional theory calculations) DFT to provide atomistic insights understanding of the electronic and structural properties of the synthesized CuONPs. Since DFT cannot handle a real nanoparticle direct, so we choose (CuO)4 cluster model41. The initial structural model of the (CuO)4 cluster was constructed using Avogadro (Version 1.2.0; https://avogadro.cc/) molecular modeling software. Geometry optimization at the molecular level and single-point energy calculations were performed employing the B3LYP functional42 was performed to remove unfavorable contacts and obtain a reasonable starting configuration. The optimized structure from Avogadro was subsequently used as input for DFT calculations in ORCA (Version 5.0.4; https://orcaforum.kofo.mpg.de/). The def2-TZVP basis set was used for all atoms (C, H, O, and N)43. The energies of the highest occupied molecular orbital (EHOMO) and lowest unoccupied molecular orbital (ELUMO) were determined, and relevant quantum chemical descriptors including the energy gap, chemical hardness, softness, electronegativity, and electrophilicity index were subsequently calculated44. Molecular docking Molecular docking studies were performed using AutoDock 4.2 package and AutoDock Tools version 1.5.6 (http://mgltools.scripps.edu)45 to investigate the binding interaction between the (CuO)6 cluster and the target protein. A grid box was defined around the active/binding site of the protein to allow free movement of the (CuO)6 cluster during docking. Analysis of docking results were done using Pymol software46(Version 3.1.6.1; https://www.pymol.org/). Preparation of (CuO)6 Cluster (Ligand) CuONPs were modeled using a (CuO)6 cluster, which represents the local coordination environment of CuONPs at the atomic level. The (CuO)6 cluster geometry was constructed using Avogadro software47. The structure was initially optimized using the Universal Force Field (UFF) to remove steric strain. The optimized structure was then exported in PDB format and further processed using AutoDock Tools. Partial charges were assigned to Cu and O atoms, and Gasteiger charges were applied. Non-polar hydrogens were merged, and the prepared (CuO)6 cluster was saved in PDBQT format for docking analysis. Protein preparation The target protein structure was retrieved from the Protein Data Bank (PDB) in .pdb format. Prior to docking, the protein was prepared using AutoDock Tools by removing water molecules, heteroatoms, and any co-crystallized ligands. Polar hydrogen atoms were added, and Kollman charges were assigned to the protein. The prepared protein structure was saved in PDBQT format, which is compatible with AutoDock docking simulations. Results and discussion Qualitative pharmocognostic evaluation of extract (A. indica + A. vera) The qualitative phytochemical screening confirms that A. indica + A. vera extract contains diverse bioactive constituents that not only justify its pharmacological potential but also support its effectiveness as a green reducing and stabilizing agent (Table 1). The presence of carbohydrates indicates the existence of polysaccharides and sugars, which are known to contribute to biological activities such as wound healing and immunomodulation. Tannins and phenolic compounds, well-known for their strong antioxidant and antimicrobial properties, play a crucial role in free-radical scavenging and metal-ion chelation, thereby enhancing the biological efficacy of the extract. The detection of flavonoids suggests significant antioxidant, anti-inflammatory, and antimicrobial potential, as these compounds are capable of donating electrons or hydrogen atoms to neutralize reactive oxygen species. Alkaloids, identified in the extract, are pharmacologically important constituents associated with antimicrobial, analgesic, and anti-inflammatory activities. The presence of saponins is indicative of surface-active compounds that contribute to membrane permeability and antimicrobial action, while terpenoids are known for their anti-inflammatory, antioxidant, and antimicrobial properties. The detection of glycosides further supports the therapeutic potential of the extract, as glycosidic compounds are associated with diverse biological functions including antioxidant and antimicrobial effects. The absence of quinones, cardioglycosides, coumarins, anthraquinones, and anthocyanosides suggests that these classes of compounds do not significantly contribute to the biological activity of the present extract, thereby narrowing down the phytochemical groups responsible for its observed pharmacological effects. Overall, the phytochemical profile confirms that the A. indica + A. vera extract is rich in bioactive compounds capable of acting as reducing, stabilizing, and capping agents, which is particularly relevant for green synthesis of metal oxide nanoparticles. The presence of phenolics, flavonoids, tannins, and terpenoids supports their role in metal ion reduction and nanoparticle stabilization, as well as in imparting enhanced antioxidant, antimicrobial, and anti-inflammatory activities. Table 1Preliminary phytochemical screening of plant extract showing the presence (+) and absence (−) of major bioactive constituents.Sr. No.TestResultInterpretation1.Carbohydrate+veReducing agent in CuONPs synthesis2.Tannin+veContribute to antioxidant activity and potential metal ion chelation during nanoparticle formation3.Saponin+veNatural surfactant properties, which may enhance stabilization and dispersion of nanoparticles.4.Flavonoid+veRich antioxidant compounds capable of reducing metal ions and improving biological activity.5.Alkaloid+vePotential antimicrobial and pharmacological activity of the extract.6.Quinone-veQuinone-type redox compounds are not significantly involved in the extract’s bioactivity.7.Glycoside+veMay contribute to therapeutic properties and assist in stabilization of synthesized nanoparticles.8.Cardioglycoside-ve-9.Terpenoid+vePotential anti-inflammatory and antimicrobial properties.10.Coumarine-ve-11.Anthraquinone-ve-12.Anthocyanosides-ve-13.Phenols+veStrong antioxidant potential and possible involvement in metal ion reduction and nanoparticle stabilization. Preliminary phytochemical screening of plant extract showing the presence (+) and absence (−) of major bioactive constituents. Biogenic surface chemistry analysis via FTIR Fourier transform infrared spectroscopy is a widely employed analytical technique for elucidating structural features of materials and identifying their characteristic functional groups. The FTIR spectrum of the A. indica + A. vera extract showed prominent absorption bands corresponding to O–H, C–H, C = O and C–O functional groups, indicating the presence of phenols, flavonoids, proteins and polysaccharides. The noticeable shift and reduction in intensity of these peaks after CuONPs formation indicate the involvement of phytochemicals in the reduction of Cu2+ ions and surface stabilization of the nanoparticles. After the formation of CuONPs, noticeable shifts and intensity reductions in these bands were observed, suggesting the involvement of phytochemicals in the reduction and stabilization process. A characteristic absorption band at 542 cm− 1 was attributed to Cu–O stretching vibrations, confirming the successful formation of CuONPs. These results demonstrate that the bioactive compounds present in the A. indica + A. vera extract acted as effective reducing and capping agents during green synthesis. The presence of bioactive phytochemicals on the surface of CuONPs may contribute to their enhanced antimicrobial and antioxidant activities. The FTIR spectrum of the extract showed characteristic absorption bands at 3230, 2923, 1661, 1372, 1262, and 1187 cm− 1 corresponding to O–H stretching, C–H stretching, C = C stretching, –CH3 bending, C–O stretching, and C–O–C functional groups, respectively. After nanoparticle formation, these peaks shifted to 3221, 2892, 1652, 1367, 1238, and 1152 cm− 1, indicating the interaction of phytochemical constituents with Cu2+ ions during reduction and stabilization of CuONPs. Furthermore, the appearance of a new absorption band at 542 cm− 1 in the synthesized nanoparticles confirmed the formation of Cu–O bonds, thereby validating the successful synthesis of CuONPs. The observed peak shifts suggest the active participation of hydroxyl, carbonyl, and oxygen-containing biomolecules from A. indica and A. vera extracts in the bioreduction and capping process. Comparative FTIR spectral data of plant extract and green synthesized CuONPs indicating functional group shifts, assignments, and their involvement in reduction, capping, and stabilization processes is given in Table 2. FTIR spectrum of CuONPs is given in Fig. 2. Table 2Comparative FTIR spectral data of plant extract and green synthesized CuONPs.Sr. NoWavenumber(cm− 1)AssignmentInterpretationReferenceExtractCuONPs1.32303221O-H stretchingInvolvement of phytochemicals in reduction by binding OH group with Cu2+ surface 48 2.29232892C-H stretchingInteraction of organic moieties with CuO surface 49 3.16611652C = C stretchingInteraction of carbonyl or amide group with Cu2+ ions 50 4.13721367-CH3 bendingSupports capping and stabilization-5.12621238C-O stretchingCoordination of C-O group with Cu2+ ions 50 6.11871152C-O-CBinding of oxygen containing group with CuO surface-7.-542Cu-OFormation of CuONPs- Comparative FTIR spectral data of plant extract and green synthesized CuONPs. FTIR spectrum of newly synthesized CuONPs. PXRD-based structural and microstructural analysis XRD is a powerful analytical technique widely used to investigate the crystalline structure and phase composition of nanoparticles. The crystalline nature and phase purity of the biosynthesized CuONPs were investigated using XRD analysis52. The crystallite size (D) was calculated using the Debye–Scherrer equation given in Eq. 5: D = (kλ)/(βcosθ) (5). Where k is the proportionality constant (k = 0.94); λ (= 1.5406Å) is the X-ray wavelength coming from Cu-Kα; β is the full width at half maximum (FWHM) of the diffraction peak in radians; θ is the Braggs’ angle in degree. The average crystallite size of the synthesized CuONPs, calculated using the Debye–Scherrer equation from the major diffraction peaks, was found to be approximately 26.3 nm, confirming the nanocrystalline nature of the sample. Low FWHM (β ≈ 0.005–0.007 rad) values represents nanocrystalline nature of sample. Sharp peaks indicated the crystalline nature of nanoparticles. The CuONPs exhibited diffraction peaks at 2θ = 32.460, 35.710, 38.330, 47.990, 53.210, 58.270, 60.720, 66.840, and 68.100 correspond to miller indices (110), (-111), (111), (-202), (020), (202), (-113), (-311) and (220) respectively. These planes are well in agreement with JCPDS no. 89-2531, which confirms the formation of CuONPs53. The crystallite sizes estimated from XRD using Scherrer’s equation (~ 26.3 nm) are smaller than the particle sizes observed by SEM and TEM (~ 20–50 nm), which is expected, as a single nanoparticle may consist of multiple crystallites. This indicates the polycrystalline nature of the synthesized CuONPs. Furthermore, the absence of additional diffraction peaks corresponding to Cu2O, [Cu(OH)2], or other impurity phases confirmed the phase purity of the synthesized CuONPs. The XRD spectrum and data of the CuONPs were given in Fig. 3; Table 3 respectively. XRD spectrum of newly synthesized CuONPs. Table 3XRD Data and Calculation of the Average Size of Synthesized CuONPs.S. Nokλ (Å)Peak position 2θ (0)θ (0)Cosθ (0)FWHM β (radian)D(nm)d-spacing (Å)1.0.941.540630.5115.250.96470.006423.52.732.0.941.540631.4915.740.96250.007121.22.413.0.941.540632.7416.370.95940.006822.22.324.0.941.540636.2818.140.95020.006722.71.715.0.941.540647.9223.960.91380.006126.01.596.0.941.540654.5427.270.88870.005430.21.527.0.941.540660.1930.090.86520.005530.41.408.0.941.540664.2632.130.84680.005034.21.36 XRD Data and Calculation of the Average Size of Synthesized CuONPs. UV–Visible spectroscopy UV–Visible spectroscopy of both the plant extract and synthesized CuONPs was carried out and compared to evaluate the participation of phytochemicals during nanoparticle synthesis. The UV spectrum of the plant extract exhibited absorption bands in the UV region, which are mainly attributed to phenolic compounds, flavonoids, proteins, and other bioactive constituents present in A. indica and A. vera extracts. These phytochemicals are responsible for the reduction and stabilization of Cu2+ ions during nanoparticle formation. The synthesis of CuONPs was further confirmed through UV–Visible spectral analysis recorded in the range of 200–700 nm. Compared with the crude extract, the synthesized CuONPs exhibited a distinct absorption peak at 525 nm, confirming the formation of CuONPs. The appearance of this characteristic absorption band along with the observed shift in spectral pattern compared to the plant extract indicates the successful bioreduction of Cu2+ ions and stabilization of nanoparticles by phytochemical constituents. Similar absorption behavior for biosynthesized CuONPs has been reported in previous studies54,55. The spectral variations between the extract and CuONPs further support the active involvement of plant-derived biomolecules in nanoparticle synthesis and surface capping. SEM and EDX SEM analysis revealed that the synthesized CuONPs were highly agglomerated and exhibited mixed morphological features, including sheet-like and quasi-spherical structures. A well-defined morphology could not be distinctly identified due to particle aggregation. The presence of grain-condensed nanostructures confirms the formation of nanoparticles, as such condensed grain features are absent in bulk or non-nanostructured materials (Fig. 4). Due to severe agglomeration, accurate measurement of individual particle size was not possible from SEM images56. SEM analysis clearly indicates that phytochemicals present in the A. indica + A. vera extract play a crucial role as reducing and stabilizing agents in the formation of the CuO nanostructure. Additionally, the micrographs showed noticeable porosity, which may contribute to enhanced surface area and improved biological activity. EDX analysis confirmed the elemental composition of the biosynthesized CuONPs, showing distinct peaks corresponding to Cu and O elements. The absence of impurity peaks demonstrates the purity of the sample. While the minor elemental signals may arise from phytochemical residues or sample preparation. Since the XRD analysis confirmed the characteristic monoclinic CuO phase without any impurity peaks, the synthesized nanoparticles can still be considered phase pure. EDX analysis confirmed the presence of copper and oxygen as the major elements in the synthesized nanoparticles. Quantitative analysis revealed 77.51 wt% Cu and 22.49 wt% O, which are close to the theoretical values of CuO. The atomic percentages (47.24% Cu and 52.78% O) indicate a nearly stoichiometric 1:1 ratio (Fig. 4). The elemental composition obtained from EDX analysis is summarized in Table 4. Elemental mapping images (a, b), EDX spectrum (c) and SEM micrographs (d-f) of synthesized CuONPs. Table 4The elemental composition of CuONPs obtained from EDX analysis.ElementWeight%Atomic %Cu77.5147.24O22.4952.78 The elemental composition of CuONPs obtained from EDX analysis. TEM and SAED TEM is an imaging technique used to obtain real-space images of materials at the nanoscale, while SAED is a diffraction technique performed inside TEM that provides reciprocal-space (diffraction) information from a selected region of the sample. TEM analysis reveals the morphology and particle size of CuONPs, while SAED analysis confirms their crystalline nature and phase structure. TEM micrographs reveal the presence of nearly spherical to quasi-spherical primary nanoparticles with an average size of ~ 20 nm, confirming the successful formation of CuONPs at the nanoscale. In addition to the primary nanoparticles, TEM images also show larger particles with sizes around ~ 50 nm, which are attributed to the agglomeration of smaller primary nanoparticles. These larger features are not individual particles but represent secondary clusters formed due to strong inter-particle interactions57. The agglomeration behavior can be ascribed to the high surface energy of CuONPs and the presence of residual phytochemicals from A. indica and A. vera extract acting as surface capping agents, which promote partial clustering through hydrogen bonding and van der Waals forces. The coexistence of small (~ 20 nm) and larger (~ 50 nm) particles indicates a polydispersed nanoparticle system (Fig. 5). The observed primary particle size is in good agreement with the average crystallite size obtained from XRD analysis, suggesting that each nanoparticle is composed of single or few crystallites. The SAED pattern of the biosynthesized CuONPs exhibits a series of concentric diffraction rings, indicating the polycrystalline nature of the sample (Fig. 5). The presence of continuous rings rather than discrete spots confirms that the nanoparticles consist of multiple randomly oriented crystallites58,59. The histogram for particle size distribution of CuONPs obtained from TEM analysis is given in Fig. 10. TEM and SAED images of synthesized CuONPs. IC50 values of green-synthesized CuO nanoparticles and standard ascorbic acid Determined from DPPH radical scavenging assay. Data are expressed as mean ± SD (n = 3). Statistical significance was determined using one-way ANOVA. ***p < 0.001. DLS Analysis The hydrodynamic size and size distribution of the green synthesized CuONPs were determined using a Malvern Zetasizer Nano ZS based on the DLS technique. Measurements were performed at 25 °C using distilled water as the dispersion medium. The DLS analysis revealed a Z-average size of 4407 nm (Fig. 6) with a polydispersity index (PDI) of 0.454. The significantly larger hydrodynamic diameter compared to nanoscale dimensions indicates strong aggregation of CuONPs in aqueous suspension. The PDI value suggests a moderately broad size distribution, confirming the presence of polydisperse aggregates. Furthermore, the zeta potential was found to be + 4.93 mV (Fig. 7), indicating low electrostatic stabilization and poor colloidal stability. The low surface charge facilitates inter-particle interactions and agglomeration, resulting in increased hydrodynamic size. These findings suggest that while nanosized CuONPs may be formed during synthesis, they exhibit aggregation behavior in colloidal medium due to insufficient surface stabilization by phytochemical capping agents. The surface charge arises from ionizable phytochemicals adsorbed on the nanoparticle surface during green synthesis. Nevertheless, phytochemicals present in the A. indica and A. vera extracts likely provided partial steric stabilization by adsorbing onto the nanoparticle surface, which helped maintain sufficient stability for characterization and biological applications. The hydrodynamic size obtained from DLS was comparatively higher than the particle size observed from SEM/TEM analysis. This difference can be attributed to the fact that DLS measures the hydrodynamic diameter, which includes the nanoparticle core along with the surrounding solvation layer and phytochemical capping agents derived from the plant extract used in green synthesis. The presence of bioactive compounds adsorbed on the nanoparticle surface increases the apparent particle size in aqueous suspension60,61. Particle size distribution of green synthesized CuONPs determined by DLS. Zeta potential distribution of green synthesized CuONPs measured by dynamic light scattering. The particle size distribution histogram of CuONPs. Correlation of structural, morphological and spectroscopic characterization These FTIR findings are in good agreement with the XRD results, which showed well-defined diffraction peaks corresponding to monoclinic CuO, confirming the crystalline nature of the synthesized nanoparticles. The moderate crystallite size obtained from XRD (~ 26 nm) suggests that phytochemical capping restricted excessive crystal growth, leading to nanocrystalline CuO. SEM analysis revealed nearly spherical to slightly agglomerated CuONPs, which can be attributed to the presence of organic biomolecules adsorbed on the nanoparticle surface. The FTIR-identified functional groups, particularly phenolic O–H, carbonyl C = O and amino N–H groups, act as stabilizing and capping agents, preventing uncontrolled particle growth and influencing surface morphology. The organic coating inferred from FTIR contributes to the observed surface texture and particle agglomeration in SEM micrographs. The SEM micrographs reveal agglomerated CuONPs with irregular and porous morphology. The agglomeration is attributed to the high surface energy associated with the small crystallite size (~ 26 nm) and strong inter-particle interactions, which drive the nanoparticles to minimize surface free energy by forming aggregates62. The nanocrystalline nature and surface roughness observed from XRD and SEM analyses are favorable for enhanced biological activity due to increased surface area. Thus, XRD and SEM results are in good agreement, confirming the nanocrystalline nature and morphological characteristics of the synthesized CuONPs. TEM analysis provides direct visualization of the nanoparticles, revealing primary CuONPs with sizes around ~ 20 nm, which is in close agreement with the crystallite size (~ 26 nm) obtained from XRD. Additionally, TEM images show the presence of larger particles (~ 50 nm) formed due to the agglomeration of smaller primary nanoparticles, which is consistent with the agglomeration behavior observed in SEM. This confirms a polydispersed size distribution and indicates that the larger features are secondary aggregates rather than individual nanoparticles. Overall, SAED analysis validates that the CuONPs are polycrystalline with a monoclinic crystal structure, supporting the results obtained from XRD and TEM analyses. However, DLS analysis using a Malvern Zetasizer Nano ZS revealed a significantly larger hydrodynamic diameter of 4407 nm with a PDI of 0.454. The increased hydrodynamic size compared to TEM observations suggests strong aggregation of nanoparticles in aqueous suspension. The low zeta potential value (+ 4.93 mV) indicates weak electrostatic stabilization, which facilitates inter-particle attraction and agglomeration. Thus, while primary particles are nanoscale, the colloidal system exhibits poor stability and aggregate formation. Antioxidant study The antioxidant activity of the synthesized CuONPs was assessed using the DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging assay at concentrations ranging from 20 to 100 µg/mL. CuONPs exhibited a concentration-dependent increase in radical scavenging activity. CuO nanoparticles exhibited % inhibition values increasing from 23.2 ± 0.6% at 20 µg/mL to approximately 85.9% at 100 µg/mL, indicating significant free-radical scavenging activity. The CuONPs showed the highest antioxidant potential at concentration 100 µg/mL, achieving a maximum inhibition of 85.9% µg/mL as shown in Table ST1 of supplementary file and Fig. 9. The standard antioxidant, ascorbic acid, demonstrated the highest scavenging activity with a maximum inhibition of ≈ 92–97%. The half-maximal inhibitory concentration IC50 values were determined to be 89.14 µg/mL for CuONPs, and 27.07 µg/mL for the standard antioxidant (ascorbic acid) represented in Table ST2 of supplementary file and Fig. 10 indicating that a relatively higher concentration of CuONPs is required to achieve 50% radical scavenging activity. Although CuONPs exhibited strong antioxidant activity, their IC50 value was higher than that of ascorbic acid, indicating comparatively lower radical scavenging efficiency. This difference may be attributed to the pure molecular nature and rapid hydrogen-donating ability of ascorbic acid, whereas CuONPs act through surface-mediated electron transfer mechanisms. Percentage inhibition of DPPH free radicals by CuONPs and ascorbic acid at different concentrations. The observed dose-dependent antioxidant activity of CuONPs suggests that increasing nanoparticle concentration enhances their ability to scavenge free radicals. This behavior can be attributed to the high surface-to-volume ratio of CuONPs, which provides a larger number of active sites for interaction with free radicals. The antioxidant mechanism may involve electron transfer or hydrogen atom donation from phytochemical-functionalized CuONPs to DPPH radicals, converting them into more stable non-radical forms. The enhanced activity at elevated concentrations may be due to the synergistic effect of CuONPs and surface-adsorbed phytochemicals derived from A. indica + A. vera extract, such as phenols, flavonoids, and tannins, which are known for their hydrogen-donating and electron-transfer abilities63. Overall, the results indicate that green-synthesized CuONPs possess significant antioxidant activity, making them promising candidates for biomedical and pharmaceutical applications where oxidative stress mitigation is required. The antioxidant activity observed in the present study is comparable to previously reported plant-mediated CuONPs synthesized using herbal extracts as mentioned in Table 5, where phytochemical-capped nanoparticles demonstrated enhanced DPPH radical scavenging activity due to the presence of surface-bound bioactive compounds. Table 5Comparison of biological activities of CuONPs obtained in the present study with previous reports.Biological ActivitiesPresent Study (A. indica + A. vera mediated CuONPs)Previous ReportsReferencesAntioxidantMaximum scavenging activity: 85.9%; IC50 = 89.14 µg/mLPhytomediated CuONPs showed significant DPPH scavenging activity at higher concentration 69–71 Anti-inflammatoryMaximum inhibition: 78.2%; IC50 = 45.44 µg/mLGreen synthesized copper nanoparticles showed dose-dependent anti-inflammatory activity comparable with standard drugs 70,72 AntibacterialMaximum inhibition zone: 23 ± 0.6 mm against B. subtilis at 900 µg/mLGreen synthesized CuO NPs showed inhibition zones ranging from 18–26 mm against Gram-positive bacteria in previous reports 73–75 AntifungalSignificant concentration-dependent inhibition against C. albicans and A. nigerPlant extract based CuONPs shows concentration-dependent inhibition 71–73 Comparison of biological activities of CuONPs obtained in the present study with previous reports. In-vitro anti-inflammatory study The in-vitro anti-inflammatory activity of biosynthesized CuONPs was evaluated at concentrations ranging from 10 to 70 µg/mL and compared with the standard drug sodium diclofenac. The percentage inhibition values are presented in (Table ST3 and Fig. 11). At lower concentrations (10–30 µg/mL), CuONPs showed moderate inhibition compared to diclofenac. However, at higher concentrations (50–70 µg/mL), a significant enhancement in anti-inflammatory activity was observed, reaching 78.2% inhibition, which approaches the standard drug (90.2%). This indicates that CuONPs possess substantial anti-inflammatory potential, although slightly lower than the reference drug. The IC50 value of Diclofenac sodium (28.21 µg/mL) was lower than that of CuONPs (45.44 µg/mL), indicating stronger anti-inflammatory activity of the standard drug (Table ST2 and Fig. 12). Since IC50 reflects the concentration required to inhibit 50% of inflammatory response, lower values correspond to higher potency. Although less active than diclofenac, CuONPs exhibited significant inhibitory potential, likely due to their ability to prevent protein denaturation and stabilize biological membranes. The comparatively higher IC50 of CuONPs is expected as diclofenac specifically inhibits COX enzymes and prostaglandin synthesis. The anti-inflammatory activity may also be associated with the ability of CuONPs to reduce oxidative stress and suppress inflammatory mediators generated during cellular damage. Surface-bound phytochemicals such as flavonoids, phenolics, and terpenoids from A. indica and A. vera extracts may synergistically contribute to anti-inflammatory activity through antioxidant and membrane-protective effects. The obtained value (45.44 µg/mL) falls within the reported range (40–100 µg/mL) for green-synthesized CuONPs as mentioned in Table ST3, confirming their promising anti-inflammatory potential64. Although the anti-inflammatory efficacy of CuONPs was lower than diclofenac, their substantial inhibition at higher concentrations highlights their potential as naturally derived alternative anti-inflammatory agents. Percentage inhibition of protein denaturation by CuoNPs. Comparative IC50 values of green-synthesized CuO nanoparticles and sodium diclofenac. Antibacterial study The antibacterial potential of CuONPs was assessed against E. coli, K. pneumoniae, B. subtilis, and S. aureus, with Levofloxacin as the reference drug. Based on previously reported studies, A. indica extract has demonstrated appreciable antimicrobial activity, with inhibition zones generally ranging from 10 to 25 mm against various bacterial and fungal strains, depending upon the extract concentration, solvent system, and test microorganism65,66. Similarly, A. vera extract. has been reported to exhibit moderate antimicrobial activity against both Gram-positive and Gram-negative microorganisms, with inhibition zones typically ranging from 8 to 22 mm under different experimental conditions67,68. The nanoparticles showed a clear dose-dependent response, as the inhibition zones increased progressively from 500 to 900 µg/mL for all strains tested. At 900 µg/mL, the highest inhibition was observed against B. subtilis (23 ± 0.6 mm), followed by S. aureus, E. coli, and K. pneumoniae. Although levofloxacin produced larger inhibition zones (30–33 mm), CuONPs demonstrated notable antibacterial efficacy against both Gram-positive and Gram-negative bacterial strains (Table ST4 and Fig. 13). The comparatively higher sensitivity of Gram-positive bacteria may be associated with the absence of an outer lipopolysaccharide membrane, allowing easier penetration of nanoparticles, whereas Gram-negative bacteria possess an additional outer membrane that acts as a protective barrier against nanoparticle entry. The enhanced antibacterial activity of CuONPs may be attributed to their nanoscale dimensions, high surface-to-volume ratio, and increased surface reactivity, which facilitate strong interaction with bacterial cell membranes. The antibacterial mechanism likely involves generation of reactive oxygen species (ROS), release of Cu2+ ions, and subsequent induction of oxidative stress leading to membrane disruption, lipid peroxidation, protein denaturation, enzyme inactivation, and DNA damage. Furthermore, phytochemicals adsorbed on the nanoparticle surface from A. indica and A. vera extracts may synergistically enhance antibacterial activity. The obtained results are consistent with previously reported studies (Table 5) on green synthesized CuONPs showing ROS-mediated antimicrobial effects. Overall, the findings indicate that biosynthesized CuONPs possess significant concentration-dependent antibacterial activity and may serve as promising alternative antimicrobial agents. Antibacterial activity of synthesized CuONPs. Data are expressed as mean ± SD (n = 3). Data are expressed as mean ± SD (n = 3). Antifungal study The antifungal potential of CuONPs was evaluated against C. albicans and A. niger and taking Fluconazole as standard. CuONPs exhibited significant antifungal activity in a concentration dependent manner. As the concentration increased, the zone of inhibition also increased, indicating fungal growth suppression (Table ST5 and Fig. 14). The enhanced antifungal efficacy of CuONPs may be attributed to their nanoscale size, high surface-to-volume ratio, and increased surface reactivity, which facilitate close interaction with fungal cell membranes. Such interactions can disrupt membrane integrity, increase membrane permeability, and lead to leakage of intracellular components. Furthermore, Cu2+ ions released from the nanoparticles may penetrate fungal cells and induce the generation of reactive oxygen species (ROS), resulting in oxidative stress, protein denaturation, mitochondrial dysfunction, enzyme inactivation, DNA damage, and eventual fungal cell death. Electrostatic attraction between positively charged CuONPs and negatively charged fungal cell surfaces may additionally enhance nanoparticle adherence and cellular disruption. The concentration-dependent increase in antifungal activity may also be associated with greater availability of active nanoparticle surfaces and copper ions at higher concentrations. Moreover, phytochemicals adsorbed on the nanoparticle surface from A. indica and A. vera extracts, including phenolics and flavonoids, may synergistically contribute to antifungal activity. Although the CuONPs exhibited a certain degree of agglomeration, which may reduce effective surface area and nanoparticle penetration into fungal cells, significant antifungal activity was still observed. This suggests that ROS generation, Cu2+ ion release, and phytochemical-assisted bioactivity remained sufficiently effective despite nanoparticle aggregation. The obtained results are consistent with previously reported studies (Table 5) on green synthesized CuONPs demonstrating enhanced antifungal efficacy due to phytochemical capping and ROS-mediated fungal inhibition. Overall, the findings suggest that biosynthesized CuONPs possess promising antifungal potential against pathogenic fungal strains. Antifungal activity of newly synthesized CuONPs. Data are expressed as mean ± SD (n = 3). DFT Calculations Density functional theory (DFT) calculations were carried out to investigate the electronic properties and chemical reactivity of the synthesized CuONPs through evaluation of the frontier molecular orbitals, namely the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) (Fig. 15). The calculated quantum chemical descriptors derived from the DFT analysis are summarized in Table 6. The HOMO energy reflects the electron donating ability of the system, whereas the LUMO energy represents its electron accepting tendency. The spatial distribution and energy values of these orbitals provide valuable information regarding molecular stability, electron transfer capability, and biological reactivity. The optimized geometry of Cu4O4 cluster revealed typical Cu–O bond lengths ranging from 1.85 Å to 2.32 Å, consistent with a distorted square planar coordination environment commonly observed in transition metal oxides. The calculated HOMO and LUMO energies were found to be − 0.24549 eV and − 0.17756 eV, respectively, with a very small HOMO–LUMO energy gap (ΔE) of 0.06793 eV. Such a low ΔE value indicates high chemical reactivity, low kinetic stability, and enhanced charge transfer efficiency of the CuONPs. In comparison with systems possessing larger energy gaps, the present CuONPs are expected to exhibit superior electron mobility and stronger interaction with surrounding biological molecules. The enhanced reactivity associated with the smaller ΔE may facilitate rapid electron exchange and reactive oxygen species (ROS) generation, which can induce oxidative stress, membrane disruption, protein denaturation, and eventual microbial cell death. This observation strongly supports the significant antibacterial and antifungal activities obtained experimentally. The ionization potential (IP) and electron affinity (EA) were calculated as 0.24549 eV and 0.17756 eV, respectively. The relatively low IP value suggests that electrons can be removed easily from the CuONPs, thereby enhancing their electron donating capability and promoting redox reactions involved in biological interactions. Simultaneously, the appreciable EA value reflects the ability of the nanoparticles to accept electrons efficiently, which further contributes to their redox behaviour and free radical scavenging activity. These findings correlate well with the observed antioxidant potential in the DPPH assay. The chemical potential (µ) was calculated to be − 0.21152 eV, indicating good electronic stability and spontaneous tendency for charge transfer interactions with biomolecular targets. The electronegativity (χ) value of 0.21152 eV suggests a considerable tendency of the CuONPs to attract electrons during intermolecular interactions, thereby enhancing their affinity toward microbial proteins and cellular components. Furthermore, the low global hardness (η = 0.03396 eV) indicates a soft molecular nature with high polarizability and elevated chemical responsiveness. According to Pearson’s hard–soft acid–base (HSAB) principle, softer systems generally display greater biological reactivity due to easier electron redistribution, which may contribute to the enhanced biomedical performance of the synthesized nanoparticles. In addition, the electrophilicity index (ω) was determined as 0.6583 eV, revealing strong electrophilic character and an enhanced ability to interact with electron-rich biological sites such as amino acid residues, proteins, and nucleic acids. Such interactions may interfere with normal cellular functioning and promote antimicrobial action. The maximum charge transfer parameter (ΔNmax = 6.409) further indicates a high capacity for electronic charge transfer, supporting efficient interaction between CuONPs and biological systems. HOMO-LUMO energy gap of (Cu4O4) cluster. Table 6Quantum chemical parameters calculated from DFT calculations.Sr. No.ParametersCuONPs (Cu4O4)1.LUMO(eV)-0.177562.HOMO(eV)-0.245493.ΔE(eV)0.067934.IP(eV)0.245495.EA(eV)0.177566.µ(eV)-0.211527.η (eV)0.033969.χ (eV)0.2115210.ω (eV)0.658312.ΔNmax6.409 Quantum chemical parameters calculated from DFT calculations. Overall, the DFT-derived quantum chemical descriptors demonstrate that the synthesized CuONPs possess high electronic reactivity, strong charge transfer capability, and favourable redox properties. These characteristics collectively support the experimentally observed antibacterial, antifungal, and antioxidant activities of the nanoparticles, thereby establishing a strong correlation between the theoretical and experimental findings. Molecular docking studies Molecular docking represents an important computational approach in structure-based drug design, enabling the prediction of binding modes and interaction profiles between candidate ligands and biological targets, including proteins and calf thymus DNA (CT-DNA). Molecular modeling techniques provide flexibility in evaluating ligand conformations and estimating their binding energies within the proposed active site using advanced molecular mechanics calculations76. Molecular docking was performed using AutoDock Tools to investigate the interaction between the (CuO)6 cluster, representing copper oxide nanoparticles, and 3T88, 5H67, 3DRA and 3TY7 proteins. The molecular docking analysis demonstrated good agreement with the experimental observations. These computational investigations provided detailed insight into the interactions between the bioactive formulations and target proteins. Furthermore, the experimentally observed antimicrobial activity was substantiated through complementary theoretical docking studies. 3T88, 5H67, 3DRA and 3TY7 were selected as an antimicrobial target. The interaction involved metal–oxygen coordination and electrostatic interactions, supported by hydrogen bonding between oxygen atoms of the (CuO)6 cluster and polar residues of the protein. Visualization of the docked formulation using PyMOL confirmed that the (CuO)6 cluster occupies the catalytic pocket of the protein. Oxygen atoms of the cluster participated in hydrogen bonding interactions, while the copper center contributed to electrostatic stabilization within the active site. These interactions collectively contributed to the observed binding affinity and favorable docking score. Unlike organic ligands, the (CuO)6 cluster does not form conventional hydrophobic interactions; instead, its binding is dominated by charge-assisted interactions, which are characteristic of metal oxide–protein interfaces. This observation supports the suitability of cluster-based docking for studying nanoparticle–biomolecule interactions. The calculated binding energies for the (CuO)6 cluster ranged from − 5.4 to − 6.8 kcal/mol, indicating moderate but stable interactions. Among the studied proteins, the strongest binding affinity was observed with 3T88 and 3TY7, while slightly weaker but significant interactions were noted for 5H67 and 3DRA (Figs. 16 and 17). The docking results revealed that the synthesized CuONPs exhibited favorable binding affinity toward the target protein, indicating stable complex formation and potential inhibitory activity against microbial metabolic pathways. Levofloxacin was employed as a standard reference ligand to validate the docking protocol. The comparable binding interactions and affinity values obtained for CuONPs support the reliability of the predicted docking results. 2D interactions of CuONPs with 3DRA, 3T88, 3TY7 and 3H67 respectively. 2D interactions of CuONPs with 3DRA, 3T88, 3TY7 and 3H67 respectively. Visualization of the protein–ligand interactions generated using PyMOL (Version 3.1.6.1; https://www.pymol.org/). 3T88 (S. aureus): The (CuO)6 cluster formed stabilizing interactions with residues such as Arg76, Asp73, and Gly77, which are involved in enzymatic activity. Oxygen atoms of the cluster contributed to hydrogen bonding, while the copper center provided electrostatic stabilization within the binding pocket. 3T88 (S. aureus): The (CuO)6 cluster formed stabilizing interactions with residues such as Arg76, Asp73, and Gly77, which are involved in enzymatic activity. Oxygen atoms of the cluster contributed to hydrogen bonding, while the copper center provided electrostatic stabilization within the binding pocket. 5H67 (E. coli): The cluster interacted with Ser229, Tyr157, and Glu120, residues associated with bacterial cell wall biosynthesis. The interaction pattern suggests possible interference with enzymatic function through charge-assisted binding. 5H67 (E. coli): The cluster interacted with Ser229, Tyr157, and Glu120, residues associated with bacterial cell wall biosynthesis. The interaction pattern suggests possible interference with enzymatic function through charge-assisted binding. 3DRA (C. albicans): Docking showed interactions with residues such as His112, Glu166, and Lys73, indicating potential disruption of enzymatic activity related to antibiotic resistance mechanisms. The binding was mainly driven by electrostatic attraction and hydrogen bonding. 3DRA (C. albicans): Docking showed interactions with residues such as His112, Glu166, and Lys73, indicating potential disruption of enzymatic activity related to antibiotic resistance mechanisms. The binding was mainly driven by electrostatic attraction and hydrogen bonding. 3TY7 (B. subtilis): The (CuO)6 cluster exhibited strong interactions with Asp81, Arg144, and Tyr130, contributing to the most stable docking conformation among the studied proteins. 3TY7 (B. subtilis): The (CuO)6 cluster exhibited strong interactions with Asp81, Arg144, and Tyr130, contributing to the most stable docking conformation among the studied proteins. Implications for antimicrobial activity The favorable binding of the (CuO)6 cluster with essential bacterial and fungal proteins provides molecular-level support for the experimentally observed antimicrobial activity of A. indica + A. vera synthesized CuONPs. Interaction with proteins involved in DNA replication, cell wall synthesis, and resistance pathways may contribute to bacterial growth inhibition. The enhanced antibacterial performance may further be attributed to the synergistic effect of phytochemical capping agents, which improve nanoparticle dispersion, stability, and bioavailability. The strong binding affinity and multiple stabilizing interactions observed during docking correlate well with the significant antibacterial and antifungal activities obtained experimentally. Docking–ZOI correlation The molecular docking results of the (CuO)6 cluster showed good agreement with the experimentally observed antibacterial activity of green-synthesized CuONPs. Among the tested bacterial strains, B. subtilis and S. aureus exhibited the highest zones of inhibition, which correlated well with stronger binding energies obtained for proteins 3TY7 (− 6.8 kcal/mol) and 3T88 (− 6.6 kcal/mol), respectively. In contrast, E. coli and C. albicans showed relatively smaller inhibition zones, consistent with their comparatively weaker docking scores (5H67: −5.8 kcal/mol; 3DRA: −5.4 kcal/mol) (Table 7). This trend suggests that stronger protein–cluster interactions may facilitate enhanced antibacterial effects. Although molecular docking does not directly simulate the bulk nanoparticle behavior, the observed correlation between docking affinity and zone of inhibition supports the role of initial bio–nano interactions in influencing antibacterial performance. The results further indicate that CuONPs interact more effectively with Gram-positive bacteria than Gram-negative bacteria, likely due to differences in cell wall architecture and surface charge. Overall, the docking results provide supportive mechanistic insight that complements the experimental antibacterial findings, validating the use of the (CuO)6 cluster as a representative model for CuONPs. The enhanced binding affinity and stable interactions observed during docking correlate well with the experimentally observed antibacterial and antifungal activities of the synthesized CuONPs. The strong interaction with microbial proteins may contribute to membrane destabilization, inhibition of enzymatic pathways, oxidative stress induction, and eventual microbial cell death. Therefore, the docking analysis provides theoretical support for the experimentally observed biomedical efficacy of the nanoparticles. Table 7Correlation of binding energy (kcal/mol) of CuONPs with zone of inhibition (mm).Bacterial strainPDB ID used for dockingDocking binding energy (kcal/mol)Zone of inhibition(mm)Correlation S. aureus 3T88 −6.614–22Strong docking + larger ZOI E. coli 5H67 −5.812–21Moderate docking + moderate ZOI B. subtilis 3TY7 −6.815–23Strongest docking + highest ZOI C. albicans 3DRA −5.412–21Moderate docking + moderate ZOILevofloxacin (standard)——22–33Reference control Correlation of binding energy (kcal/mol) of CuONPs with zone of inhibition (mm). Structure-property-activity relationship of CuONPs The biological performance of synthesized CuONPs was strongly influenced by their physicochemical characteristics, including crystallite size, morphology, surface functionalization, particle size distribution, and surface charge. Structure-property relationship The small crystallite size and nanoscale morphology significantly increased the surface area, enhancing surface reactivity. The presence of phytochemical capping agents improved dispersion and prevented rapid oxidation or excessive aggregation. The zeta potential facilitated interaction with negatively charged bacterial cell membranes, promoting membrane disruption. The larger hydrodynamic size observed in DLS compared to TEM confirmed slight aggregation in aqueous medium, which may influence diffusion and bioavailability. Thus, the structural parameters directly influenced the physicochemical properties such as: Surface reactivity, Colloidal stability, Electron transfer capability, ROS generation potential. Structure–activity relationship The concentration-dependent DPPH radical scavenging activity can be attributed to High surface area due to nanoscale size, Electron transfer capability of Cu2+/Cu+ redox cycling and Surface phytochemicals acting as hydrogen or electron donors. The protein denaturation inhibition assay showed significant anti-inflammatory potential. This may be due to the Surface-bound bioactive compounds stabilizing protein structure, Redox modulation ability of CuONPs and Controlled ROS generation reducing inflammatory mediators. Smaller particles enhance interaction with protein molecules, leading to better inhibition efficiency. The antimicrobial efficiency against Gram-positive and Gram-negative strains is strongly correlated with the Small particle size enabling membrane penetration, Surface charge facilitating electrostatic attraction, ROS generation causing oxidative stress and Release of Cu2+ ions disrupting cellular enzymes and DNA. Gram-positive bacteria showed comparatively higher susceptibility due to simpler cell wall structure, allowing easier nanoparticle penetration. Comparative analysis of green vs. chemically synthesized CuO nanoparticles Green synthesis uses bioactive molecules as reducing + capping agents, reducing hazard and cost while improving biocompatibility compared to conventional chemical routes. Green synthesis of CuONPs involves Bioactive compounds from the plant extract remain bound to the nanoparticle surface, acting as both reducing and capping agents. These phytochemicals contribute additional functional groups that enhance antioxidant and antimicrobial effects through synergistic mechanisms (free radical quenching and membrane interaction). While Chemical CuONPs were formed via strong reductants without bioactive capping; activity is mainly due to CuO physicochemical effects like ROS generation, metal ion release, and surface interactions. The comparative analysis demonstrates that green synthesized CuONPs outperform chemically synthesized counterparts across physicochemical stability and biological activity parameters. Green CuONPs possess higher colloidal stability (greater absolute zeta potential) and enhanced bioactivity (lower IC50 in antioxidant and anti-inflammatory assays and larger antimicrobial inhibition zones). This enhancement can be attributed to the capping of active phytochemicals on the nanoparticle surface, which likely contributes synergistically to the observed effects. In contrast, chemically synthesized CuONPs lack this bioactive interface, which may limit functional performance despite similar core sizes. A comparative analysis of green synthesized CuONPs with chemically synthesized CuONPs is given in Table 8. Table 8Comparative analysis of green synthesized CuONPs with chemically synthesized CuONPs.MaterialsSynthesis MethodParticle SizeMorphologyBiological activityBacteria/ FungiZOIRef.CuOGel combustion method20 ± 1.24 nm and 28.9 ± 1.22 nm-Antibacterial E.coli B. subtilis S. aureus 2.42.02.2 77 Cu2OReverse micelle technique35.5 ± 2 nm and 30.3 ± 2 nmsphericalAntibacterial B. subtilis 1.6 78 CuOLaser Ablation technique3–40 nm.spherical shapeAntibacterial E.coli 1.8 79 CuOCoprecipitation-petals with porous structuresAntibacterial and Antifungal B. subtilis E.coli E. faecalis S. aureus C. albicans 2.32.52.82.81.7 80 CuONPsExtract20–50 nmQuasi- sphericalAntimicrobial, Antioxidant, Anti-inflammatory B. subtilis E.coli S. aureus C. albicans 12–33PresentWork Comparative analysis of green synthesized CuONPs with chemically synthesized CuONPs. E.coli B. subtilis S. aureus 2.4 2.0 2.2 B. subtilis E.coli E. faecalis S. aureus C. albicans 2.3 2.5 2.8 2.8 1.7 Antimicrobial, Antioxidant, Anti- inflammatory B. subtilis E.coli S. aureus C. albicans Present Work Conclusion In the present investigation, CuONPs were successfully synthesized through an environmentally benign green route using aqueous extracts of A. indica and A. vera as reducing and stabilizing agents. The adopted synthesis strategy provided a cost-effective, sustainable, and scalable alternative to conventional chemical methods while minimizing the use of toxic reagents. Comprehensive physicochemical characterization through SEM, TEM, SAED, FTIR, XRD, DLS, and EDX analyses confirmed the successful formation of polycrystalline monoclinic CuONPs with particle sizes ranging from 20 to 100 nm. The synthesized nanoparticles exhibited significant antioxidant, anti-inflammatory and antimicrobial activities against multidrug-resistant microbial strains, thereby demonstrating their multifunctional biomedical potential. The main objectives of this study was to develop green-synthesized copper oxide nanoparticles and systematically evaluate their antioxidant, anti-inflammatory and antimicrobial activities, all of which were successfully achieved through experimental investigations. Furthermore, DFT and molecular docking studies provided valuable insight into the electronic structure, chemical reactivity, and possible interaction behavior of the synthesized nanoparticles with selected biological targets. The low HOMO–LUMO energy gap and favorable docking interactions supported the experimentally observed biological efficacy and strengthened the proposed structure–property–activity relationship. Overall, the combined experimental and theoretical findings highlight the promising applicability of green-synthesized CuONPs in antimicrobial formulations, wound healing systems, and nanotherapeutic platforms. However, certain limitations remain in the present study. Agglomeration of nanoparticles was observed in SEM and TEM analyses, which may influence particle uniformity and biological performance. In addition, long-term stability studies and comparative evaluation with standard commercial antimicrobial agents were not explored. Therefore, further investigations focusing on detailed mechanistic pathways, toxicity profiling, pharmacological evaluation, and stability enhancement are required to expand the practical and clinical applicability of these nanoparticles. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Author contributions **Annu Devi** : conceptualization, methodology, formal analysis, investigation, data curation, writing original draft. **Madhu** : methodology, review, data curation. **Ashu Chaudhary** : supervision, conceptualization, methodology, formal analysis, investigation, data curation, writing, review and editing, resources. Funding This work doesn’t receive funding. Data availability The data that support the findings of this study are available from the corresponding author upon reasonable request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.